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Abstract: The aim of this study was to evaluate the soft tis-
sue response to poly(e-caprolactone) (PCL) implants with and
without carbonate-substituted hydroxyapatite (CHA) coating
compared to the commonly used titanium alloy (Ti-6Al-4V)-
machined surface. Experimental materials were implanted
subcutaneously in New Zealand white rabbits for 5 weeks.
The tissue attachment strength, as evaluated by a tissue peel
test, histological and histomorphology analysis, as well as
scanning electron microscopy were compared between
groups. The peel test result revealed no statistically signifi-
cant difference between groups. Histological analysis found
fibrous capsule formation around all implant materials. The
fibrous capsule around PCL implants with and without CHA
coating was significantly thinner compared with the capsule
thickness around the titanium implants. However, the inflam-
matory cells, as present at the fibrous capsule-implant inter-
face, were found to be significantly lower in the Ti-group. In
conclusion, the current data do not prove that PCL or PCL
with a CHA coating results in a superior soft tissue response
compared with a machined titanium implant. VC 2013 Wiley
Periodicals, Inc. J Biomed Mater Res Part A: 101A: 2258–2266, 2013.
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INTRODUCTION
In previous studies, a titanium modular mandibular endo-
prosthesis has been developed to repair segmental defects
of the mandible, which demonstrated stability and good ﬁx-
ation to bone in animal studies.1,2 However, in some instan-
ces, dehiscence has proven to be a problem especially when
the soft tissue does not adhere to the body of device, with
subsequent exposure of the prosthesis.3
It is known that implant surface chemistry, shape, and
mechanical properties are all factors that affect the implant-
soft tissue adhesion.3 For example, implant surface topogra-
phy has a major effect on implant tissue response.4 Smooth-
surfaced implants result in a foreign body reaction, which is
characterized by ﬁbrous tissue encapsulation of the implant
and the presence of inﬂammatory cells at the implant–soft
tissue interface. On the other hand, implant surface rough-
ness can have a favorable effect on the soft tissue response.
It has been suggested that implants with a surface rough-
ness value of 3.3 microns or larger tend to become inﬁl-
trated with inﬂammatory tissue, while implants with a sur-
face roughness value 1 to 2 microns porosity appear to
allow direct ﬁbroblast attachment to the surface, which is
supposed to be independent of the physico-chemical nature
of the implant surface.4 Although the relationship between
material surface topography and cellular behavior is com-
plex and still not fully understood, Unadkat et al. hypothe-
sized that changes in the surface topography can affect cel-
lular responses to a material by mimicking the inﬂuence
and action of growth factors.5 Substrate surface features
have been shown to induce signiﬁcant modulation of focal
adhesion formation, cytoskeletal development, and cellular
spreading, changes that are subsequently transduced to sig-
naling pathways, affecting functional differentiation through
integrin-speciﬁc signaling pathways.6 Surface roughness and
total surface area of an implant can be favorable for
increased cell adhesion and migration as well as the
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production of extracellular matrix (ECM). In view of this,
implant surfaces with a texture such as nodes, pores,
grooves, or random patterns are often associated with a
marked change of cell morphology, cell activity, and cellular
production of autocrine as well as paracrine regulatory fac-
tors compared to the smooth surface.7
Implant surface roughness can be created by adding or
subtracting material from the implant surface. The addition
of material can be done by a coating procedure,8,9 that is ti-
tanium plasma spraying, and subtraction can be done by
grit-blasting 10–12 or etching procedures.13,14 Most of the
studies to date have investigated the effect of increased sur-
face roughness of the implant on bone regeneration. How-
ever, less studies have investigated the effect of increased
surface roughness of the implant on soft tissue attachment.
Lee et al. designed an experiment to study the effect of tita-
nium surface modiﬁcation on soft tissue attachment.3 Both
machined surface and -etched titanium bullets were
implanted for 6 months in the muscle of Macaca fascicularis
monkeys. The histological results showed a lack of direct
contact between muscle tissue and machined titanium
implant surface. Also, surface etching did not result in a sig-
niﬁcant improvement to the soft tissue attachment com-
pared to the machined titanium surface.3
Although titanium is preferred for bone reconstruction
due to its mechanical strength and ability to withstand
long-term loading, tissue adaptation to the titanium surface
is still limited. The soft tissue response to an implant mate-
rial is also dependent on the mechanical properties of the
biomaterial.15 In general, less stiff biomaterials improve the
soft tissue response. The mechanical properties of polymers
are easier to ﬁne-tune to get a better soft tissue response
than metals, like titanium. A candidate material, as can be
used for the fabricating of a modular endoprothesis with an
improved soft tissue adaptation, is poly(e-caprolactone)
(PCL). This material has several advantages over other poly-
mers. It is more stable in ambient conditions, signiﬁcantly
less expensive, and is readily available in large quanti-
ties.16,17 In addition, PCL can be easily combined with other
materials to further formulate the tissue response. Active
screen plasma surface modiﬁcation has been shown to
improve osteoblast cell adhesion and spreading on the PCL
surface18, while chemical hydrolysis to introduce carboxy-
late groups onto the surface of the PCL was found to
improve surface wettability and roughness of the PCL,
which was correlated with increased cell attachment.19 Sev-
eral techniques are available to manufacture an implant
from PCL. One of the approaches is laser sintering, where
small PCL particles are selectively fused layer by layer by a
high-power laser to build a three-dimensional (3D) device.
This method allows adaptation of the mechanical properties
of the ﬁnal implant.20 Selective laser-sintered (SLS) and
solid free-form fabrication (SFF) manufactured PCL scaffolds
with a porosity between 37 and 55% were reported to have
mechanical properties comparable with human trabecular
bone. The compressive modulus of such scaffolds was found
to be within the 52–68 MPa range, and the ultimate com-
pressive strength was within the 2.0–3.2 MPa range, which
makes this material an attractive substitute for human bone
and its application for bone reconstruction in load-bearing
areas.20
For the current study, we hypothesized that implants
made of PCL would lead to better soft tissue adaptability
and adhesion than commercially pure titanium implants. In
addition, we supposed that surface roughening, created by
the deposition of a carbonate-substituted hydroxyapatite
(CHA) coating on PCL, would further improve the soft tissue
response. Therefore, implants were incubated in modiﬁed
simulated body ﬂuid (mSBF), which resulted in the nuclea-
tion and growth of a CHA coating on the implant surface.
A subcutaneous rabbit model was used to study the soft
tissue response. Analysis after 5 weeks of implantation was
based on a tissue peel test to determine the force required
to separate the soft tissue from the various implant surfaces
and on light microscopy examination.
MATERIALS AND METHODS
Implant materials
Non-coated PCL, CHA-coated PCL, and commercially tita-
nium (Ti) implants were manufactured. The implants were
rectangular-shaped, measured 10  5  3 mm, and were
provided with rounded off corners and edges. The PCL
implants were fabricated via laser sintering as previously
reported.20 The PCL implants were used as-received or
were coated with CHA by incubation at 37C in mSBF for 8
days under continuous rotation. Prior to mSBF incubation,
the PCL plates were hydrolyzed in a 1 M NaOH for 60 min.
After hydrolysis, plates were rinsed and incubated in the
mSBF. The mSBF solution has a similar composition to that
of human plasma and also to that of the SBF solution
reported by Kokubo et al., but with double the concentra-
tion of calcium and phosphate to enhance mineral growth,
and was prepared as previously reported.21,22 Brieﬂy, 141
mM NaCl, 4.0 mM KCl, 0.5 Mg SO4, 1.0 mN MgCl2, 4.2 mM
NaHCO3, 5.0 mM CaCl2, and 2.0 mM KH2PO4 were dissolved
in deionized ultra-ﬁltered water, pH was adjusted to 6.8
with 2N HCl or 2N NaOH.
Prior to their use in the in vivo study, PCL and CHA-
coated PCL implants were sterilized by ethylene oxide, and
Ti-plates were sterilized by autoclave.
Animal model and implantation procedure
The animal experimental protocol was approved by the
Institutional Animal Care and Use Committee (IACUC) of
Singhealth, Singapore. The animal laboratory was certiﬁed
by the International Association for Assessment of Labora-
tory Animal Care (IAALAC).
Nine female New Zealand white rabbits, 3–4 months old,
were used in this study. The surgery was performed under
general anesthesia by intramuscular injection of 1.5 mg Ke-
tamine (Parnell Laboratories, Alexandria, Australia). Anes-
thesia was maintained by 1-1.5% isoﬂurane gas through a
mask with constant volume ventilator. Heart rate and oxy-
gen saturation were monitored during the procedure.
Prior to surgery, the skin was shaved, washed, and disin-
fected with povidone iodine 1% solution, Hexodane 0.5%
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(Chlorhexidine 0.05% W/V in Methylated Spirit 70%), and
centrimide 1% solution. Each animal was given a unique
code. Six longitudinal incisions of about 1.5 cm were made
at the left and right side of the vertebral column at 3 cm
apart from each other. Six subcutaneous pockets were pre-
pared by blunt dissection with scissors. Each of the pockets
in each animal received one of the three types of implants.
A randomization schedule was made for implant allocation,
which listed the animal’s code and the corresponding sub-
cutaneous pocket number (1–6) in each animal.
Six implants (two PCL, two CHA-coated PCL, and two Ti)
were inserted into each rabbit. With nine rabbits used, a
total of ﬁfty-four implants were inserted (18 PCL, 18 CHA-
coated PCL, and 18 Ti). After implant installation, the
wounds were closed using 3-0 VicrylV
R
intracutaneous
sutures (Ethicon, Somerville, NJ). After 5 weeks, all animals
were euthanized, and the implants with surrounding tissues
(a rectangular patch of the skin encompassing each plate)
were harvested.
After harvesting, the retrieved specimens were divided
into two equal-sized groups, that is, one group was used for
testing of the soft tissue adhesion strength, and the other
was used for histological analysis.
Peel-test procedure
Immediately after harvesting of the plates, 27 samples (nine
of each plate type) were subjected to a soft tissue peel-test
using an InstronV
R
8800 microforce tester (Instron Corpora-
tion, SatecTM, Norwood, MA) equipped with a static load cell
with a capacity of 10 N.
All specimens were prepared before installation into the
InstronV
R
machine (Fig. 1), that is, one-third of the plate sur-
face was exposed to allow its grip by the lower grip of the
machine, while the remaining two-thirds of the attached tis-
sue was kept intact to the plate for the peel test. One end of
the soft tissue was attached vertically to the upper grip of
the testing machine, and the plate surface was kept parallel
(180 degree) to the tension force. A tension force was
applied with the top upper arm of the machine, which was
moving upwards at a speed of 5 mm/min. The test was car-
ried out until tissue was completely peeled off from the
plate surface. Mechanical data were recorded, and the corre-
sponding force–displacement curves were generated. The
values of maximum force attained were then averaged, and
the standard deviations were calculated. After performance
of the peel test, the specimens were ﬁxed in 10% formalde-
hyde for further evaluation with scanning electron micros-
copy (SEM).
Scanning electron microscopy
The morphology of the plates before and after implantation
was investigated by SEM. PCL and CHA-coated PCL plates
were mounted on aluminum stubs and sputter coated with
a thin layer of gold. Samples were imaged under high vac-
uum using a Philips XL30 FEG scanning electron microscope
(Hillsboro, Oregon) operating at 10 kV. Ti-plates were
mounted on stub and examined at 20 kV without gold sput-
ter coated.
Histological analysis
Before histological preparation, the specimens with their sur-
rounding tissues were immersed for 1 week in buffered 10%
formalin solution for ﬁxation (ICM Pharma Pte, Singapore),
and then dehydrated in a graded series of alcohol and embed-
ded in methylmetacrylate. After polymerization, the tissue
blocks were mounted in a modiﬁed inner circular saw
microtome (LeicaV
R
RM 2165, Wetzlar, Germany). At least,
three histological sections were made from each specimen.
Sections had a thickness of 10–15 lm and were stained with




All sections were observed and independently scored by
two blinded observers (N Chanchareonsook and Lee S)
using an established soft tissue histology grading scale,23 as
shown in Table I. When the two observers disagreed on a
score, the section was discussed until a consensus was
reached. The thickness of capsule around implants was
measured in micrometers (lm) using ‘CellA’ digital imaging
software program (OlympusV
R
, Germany). Subsequently, the
means of capsule thickness of each implant type were
calculated.
Statistical analysis
Data from the peel test and histological measurements were
statistically analyzed using SAS 9.2 statistical software (SAS
Institute, Cary, North Carolina). Measurements were eval-
uated by analysis of variance with pair-wise comparison
post test to identify the groups that differed from each
other. This was done with no correction for the Type I error




At 5 weeks after surgery, all rabbits tolerated the implant
installation very well. Tissue necrosis was observed in only
one animal in the area where ketamine was injected. This
site was close to a CHA-coated PCL plate. Therefore, this
specimen was subsequently excluded from further analysis
to avoid an effect on the experimental results. In all other
FIGURE 1. Specimens were installed in InstronV
R
8800 machine for tis-
sue peel test: (a) before and (b) during peel test for the PCL plate.
[Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
2260 CHANCHAREONSOOK ET AL. SUBCUTANEOUS TISSUE RESPONSE TO IMPLANTS
animals, the surgical sites presented good healing without
any wound dehiscence. All plates were palpable through the
skin. It appeared that some of the plates had migrated from
the insertion site. The Ti-plates had migrated over a dis-
tance of 0–4 cm, while CHA-coated and non-coated PCL
plates had migrated by 0–1 cm.
Peel testing
Two of the 27 samples were excluded from the peel-test
study. One CHA-coated PCL was excluded due to necrosis of
skin from the effect of ketamine injection, and one Ti-plate
sample was excluded due to formation of hematoma on the
plate surface during tissue manipulation at tissue harvesting.
The average energy used for the peel test for Ti, PCL,
and CHA-coated PCL was 0.728  103, 0.543  103, and
0.274  103 J, respectively. The average peel force for Ti,
PCL, and CHA-coated PCL was 0.17, 0.104, and 0.098 N,
respectively (Fig. 2).
Statistical analysis of the data showed no signiﬁcant dif-
ference between the mean peak of peel force and energy of
peeling between the three experimental materials.
Surface morphology
It is shown from SEM images that the non-coated PCL
implants have rougher surface appearance than those of the
Ti-implants. The CHA coating, as deposited on the PCL
implants, had a microscale plate-like morphology and
increased the surface roughness of the PCL implants com-
pared with the non-coated ones. After 5 weeks of implanta-
tion, the surfaces of the implants after the peel test were
not altered considerably compared to images before implan-
tation (Fig. 3). There were no remaining tissue and cells
visible on all plate types after the peel test.
Histological analysis
Evaluation of the histological sections revealed a fairly uni-
form tissue response for the three types of implant. In all
sections, normal skin and underlying tissues, including fat
tissue, could be observed. The surface of both CHA-coated
and non-coated PCL plates appeared to be rougher com-
pared with those of the Ti-implants. The CHA layer on the
coated PCL implants could easily be identiﬁed, and a thin
red layer on the outer surface of these implants was
visible.
All implants were found to be surrounded by a ﬁbrous
tissue capsule. This capsule was 7-8 cell layers in thick-
ness for PCL and CHA-coated PCL implants and 14-17 cell
layers for Ti-implants. The capsule had an aligned mor-
phology with collagen bundles running parallel to the
FIGURE 2. Peel test analysis of machined surface Ti-implant, non-coated PCL implant, and PCL surface coated with carbonate-substituted hy-
droxyapatite (CHA). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
TABLE I. Soft Tissue Histologic Grading Scale (adapted and modified by Jansen et al., 1994)
Evaluation Response Score
Capsule qualitatively Capsule is fibrous, mature, not dense, resembling connective or fat tissue in the
non-injured regions
4
Capsule tissue is fibrous but immature, showing fibroblasts and little collagen 3
Capsule tissue granulous and dense, containing both fibroblasts and
many inflammatory cells
2
Capsule consists of masses of inflammatory cells with little or no signs of
connective tissue organization
1
Cannot be evaluated because of infection or other factors not necessarily related
to the material
0
Interface qualitatively Fibroblasts contact the implant surface without the presence of macrophages or
leucocytes
4
Scattered foci of macrophages and leucocytes are present 3
One layer of macrophages and leucocytes are present 2
Multiple layers of macrophages and leucocytes are present 1
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FIGURE 3. Scanning electron microscopy (SEM) images of Ti-plates, coated, and non-coated PCL plates before and after 5 weeks of subcutane-
ous tissue implantation in the rabbit model: (a) non-coated PCL before surgery, (b) non-coated PCL after implantation and peel test, (c) coated
PCL before surgery, (d) coated PCL after implantation and peel test, (e) machined-surface titanium plate before surgery, and (f) machined-surface
titanium plate after implantation and peel test. The images demonstrated the rough surface of each implant type, that is, the excellent pattern of
microscale plate-like morphology of coated PCL as well as the machined surface appearance of the Ti-plates. The implant surfaces in all type
did not show any remnant of connective tissue as left on the surface.
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implant surface. Occasionally inﬂammatory cells were seen
in the interface between the capsule and implant surface.
The presence of inﬂammatory cells was more evident for
the PCL implants compared with the titanium implants
(Fig. 4).
Histomorphometry
The average capsule thickness around the PCL implant was
34.3 6 15.5 mm, around CHA-coated PCL 50.8 6 16.4 mm,
and around the Ti-plate was 62.2 6 15.7 mm. Statistical
testing revealed that the capsule around the non-coated PCL
FIGURE 4. Histological images of non-coated PCL plates, coated PCL plates, and Ti-plates after 5 weeks of subcutaneous tissue implantation in
the rabbit model Ti: titanium implant; FC: fibrous capsule; PCL: polycaprolactone implant; C: carbonate-substituted hydroxyapatite (CHA) coat-
ing; IC: inflammatory cells (methylene blue and basic fuchin ). (a) to (c) magnification of 4, (d) to (f) magnification of 10, and (g) to (i) magnifi-
cation of 40. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
TABLE II. The Average Capsule Thickness and Pair-wise Comparisons Between Implant Type. The Result Showed Significant





Thickness (mm) (6SD) Non-coated PCL CHA-coated PCL Ti
Non-coated PCL 34.3(615.5) - 0.0003** <.0001**
CHA-coated PCL-plate 50.8(616.4) 0.0003** - 0.0101**
Ti 62.2(615.7) <.0001** 0.0101** -
** Statistically significant difference (p  0.05).
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plate was signiﬁcantly thinner compared with the CHA-
coated PCL and Ti-plates (Table II). Also, the capsule around
the CHA-coated PCL plates was found to be signiﬁcantly
thinner compared to that around the Ti-plates (Table II).
The soft tissue grading scores for capsule quality and
interfacial tissue response are depicted in Figure 5. The
mean soft tissue grading score for capsule quality of PCL,
CHA-coated PCL, and Ti-implants are 1.6 6 0.6, 2.5 6 0.5,
and 2.8 6 0.4, respectively. The mean soft tissue grading
score for interface quality of PCL, CHA-coated PCL, and Ti-
implants are 1.0 6 0.0, 1.4 6 0.8, and 3 6 0.7 (Fig. 5),
respectively.
Statistical analysis by Fisher’s exact test on global null
hypothesis testing showed homogeneity of data distribution
for all three implant groups. The comparison of percent
score distribution of capsule quality and interface quality
between implant types was analyzed by pair-wise compari-
sons. The results show that all three groups differed signiﬁ-
cantly relative to capsule quality and capsule interface
quality.
DISCUSSION
Soft tissue adherence between host tissues and an implant
is important to minimize implant-soft tissue dehiscence, to
improve the long-term performance of a device in vivo, and
to reduce the occurrence of infection. Metallic and poly-
meric implants are known to become surrounded by a
ﬁbrous tissue capsule after their installation in soft body
tissue.3,24,25 Physical properties, such as implant shape, me-
chanical properties of the implant material, and degree of
surface roughness, as well as chemical properties, determine
the ﬁnal soft tissue response.3
In this study, rectangular plates composed of different
materials, that is, commercially pure titanium (Ti), non-
coated PCL, and CHA-coated PCL were inserted subcutane-
ously into the back of rabbits for 5 weeks. It was hypothe-
sized that (1) the PCL implant would show an improved
soft tissue response compared to the Ti-implant, and (2) the
CHA coating, as provided to the PCL plates, would further
favor the soft tissue reaction. However, histological analysis
after retrieval of the implants did not conﬁrm the hypothe-
sis. Overall, the soft tissue response to all implants was very
similar, and no direct attachment of connective tissue to the
various surfaces was observed.
Clinical observation of the implants after 5 weeks of
installation in the rabbits showed that the machined
surfaces Ti-plates had migrated over a distance of 0–4
cm. This was more than the coated and non-coated PCL
plates, which were found to have migrated 0–1 cm. Such
migrational behavior is commonly found when implants
are inserted in soft tissue without any additional ﬁxation
to the soft tissue layer and is related to the soft tissue
adhesion of each particular implant surface. The degree of
migration indicates a lack of soft tissue adhesion of the
implant surface. The current ﬁndings corroborate with an
earlier study dealing with the migration of microchips in
Beagle dogs.26 In this study, microchips made of three dif-
ferent materials, that is, bioglass, acid-etched bioglass, and
bioglass provided with a polypropylene cap, were in-
stalled in the soft tissue around head and shoulder of the
Beagle dogs for 16 weeks. Different degrees of microchip
migration were observed, which was depending on the
location and the used material. The microchips in the
shoulder, which had more muscle activity, showed a
migration up to the maximum of 11 cm. In contrast, the
microchips in the head area moved only to a maximum
distance of 2 cm from their insertion point. Furthermore,
the microchips made of etched bioglass or provided with
a polypropylene cap were found to migrate signiﬁcantly
less than microchips made of just bioglass.26
To deﬁne the level of soft tissue attachment with the
implant surface, we made use of a tissue peel test. Bobyn
et al.27 found that the increased strength of tissue attach-
ment is correlated with implantation time. Similarly, in an
earlier pilot study, we demonstrated that specimens at 2
weeks of plate implantation (result not shown) demon-
strated a poor soft tissue attachment irrespective of the
implant surface ﬁnish. Therefore, in the current study, the
implantation time was increased to 5 weeks to allow for the
maturation of the tissue attachment. Subsequently, the peel
test data demonstrated that there was no signiﬁcant
FIGURE 5. Grading scale scores of capsule quality and interface quality for PCL, CHA-coated PCL, and Ti implants. The comparison of percent
score distribution of capsule quantity, capsule quality, and interface quality between implant types were analyzed by pair-wise comparison. The
significant differences for capsule quality were found between non-coated PCL versus PCL coated with CHA (p < 0.001), non-coated PCL versus
Ti (p < .001), and PCL coated with CHA versus Ti (p ¼ .042). Significant differences for capsule interface quality were found between non-coated
PCL versus PCL coated with CHA (p ¼ 0.010), non-coated PCL versus Ti (p < 0.001) and PCL coated with CHA versus Ti (p < 0.001). [Color figure
can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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difference in peel test readings between the different
implant surfaces, and therefore, no relevant mechanical
effect of implant surface preparation on soft-tissue bonding
was observed. However, we found that during the peel test,
tissue adhesion between implant and fresh subcutaneous
rabbit specimen was fragile, and the peel test required
highly delicate tissue manipulation especially when the sam-
ples were small in size. As a consequence, the protocol for
the tissue peel test still has room for improvement in future
studies. Furthermore, the pores and channels in the PCL
structure allowed a better maintenance of moisture than
the titanium implant. This can inadvertently affect the peel
test result, as faster desiccation of the soft tissue on the
titanium implant during testing may lead to increased adhe-
sion. In future experiments, environmental control of mois-
ture and temperature should be regulated to ensure that
the soft tissue specimens remain in their optimal condition.
No previous studies are available, in which a peel test
was done for PCL. Overall, our peel force results were found
to be lower compared with previous studies. 27-29 Hacking
et al.28 studied ﬁbrous tissue ingrowth and attachment to
porous tantalum after insertion in the dorsal subcutaneous
tissue in dogs. A peel test was done using a servo-hydraulic
tensile test machine at a rate of 5 mm/min. Peel force at 4,
8, and 16 weeks was reported at 61, 71, and 89 g/mm,
respectively.28 Zhao et al.29 studied titanium ﬁber mesh
with 84.7% porosity and compared this material with coni-
cal implants coated with various compositions of bioactive
glass. Ti-mesh was inserted into the dorsal subcutaneous
soft tissue and muscles in the back of rats for 8 weeks. Tita-
nium ﬁber mesh implants showed a relatively high pull-out
force in subcutaneous tissue (12.33 6 5.29 N, mean 6 SD)
and in muscle tissue (2.46 6 1.33 N).29 Bobyn et al.27 in-
stalled porous metal plates in the subcutaneous tissue of
mongrel dogs. The largest metal pore size with the approxi-
mate range of 50–200 microns produced a mean peel
strength of attachment of 27.5 g/mm after 16 weeks of im-
plantation period. All these high values can be explained by
the nature of the implant material used. A highly porous
material will allow a better penetration of the soft tissues
compared with the current materials.
The histological analysis showed a lack of direct contact
between the soft tissue and implant surface. The observed
formation of a ﬁbrous capsule around the machined surface
titanium implant with the presence of none or very minimal
inﬂammatory cells is similar to a previous study.3 Titanium
is an ‘‘inert’’ material and causes a minimal immune
response and foreign body reaction in soft tissue.30 This is
the reason that many commercially available implantable
devices (such as pacemakers) are made of medical grade ti-
tanium (alloy).
In the present study, coated and non-coated PCL plates
were found to be superior compared to the Ti-implant in
terms of ﬁbrous capsule thickness. However, the ﬁbrous
capsule was found to be less mature and contained more
macrophages and inﬂammatory cells at the tissue–implant
interface than the Ti-implants. The surface modiﬁcation
with a CHA coating on the PCL plate increased the surface
roughness as shown in the SEM images (Fig. 3). PCL
implant with CHA surface coating showed a signiﬁcant
improvement in capsule quality and tissue–implant interface
quality, as observed by the reduction of inﬂammatory cells.
This effect can be due to the increased surface roughness as
created by the CHA coating. On the other hand, coating of
PCL with CHA can also change the mechanical properties of
PCL, that is, the material becomes less ﬂexible, which can
also affect the soft tissue response.
PCL matrices are known to degrade at low rates by hy-
drolysis of the ester bonds and break down to their constit-
uent monomer-hydroxycaproic acid, which then undergoes
phagocytosis. PCL is characterized by a very low hydrolysis
rate, which can vary from months to years.31 Therefore, the
degradation process of PCL during the 5 weeks implantation
period in this study was supposed to have no effect on the
study result. For PCL coated with CHA, the CHA was still
found to be intact at the end of 5 weeks and was clearly
visible in the histological sections. Nevertheless, future
research has to elucidate the effect of CHA on the biodegra-
dation rate and bone regeneration properties of PCL.
CONCLUSIONS
The data of the current study indicate that none of the
materials as well as surface modiﬁcations resulted in a
superior soft tissue response. The peel test showed that ad-
hesion of the soft tissues did not occur. Although both types
of PCL implants showed less migrational behavior compared
with the Ti-implants, soft tissue adhesion was not observed
for any of the investigated implants, as demonstrated by the
peel test data. Fibrous capsule formation around the non-
coated and CHA-coated PCL implants was less than that
around the Ti-implants. On the other hand, an increased
amount of interfacial inﬂammatory cells was present for all
PCL implants compared with the Ti-implants.
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